There are 807 resources available
YO9 - Primary refractoriness of recurrent ovarian clear cell carcinoma to anti–PD-1 inhibitor-based therapy in a patient with Lynch syndrome: Never take for granted
Presenter: Jack Chan
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: Thanyanan Baisamut (Reungwetwattana)
Session: Lung cancer in non-smokers
Resources:
Slides
Webcast
Lung: State of the art in 2022
Presenter: Jose Belderbos
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Ana Oaknin
Session: Immunotherapy in gynecological cancers: Where do we stand?
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Enrique Grande Pulido
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
Invited Discussant YO1, YO8 and YO9
Presenter: Matteo Lambertini
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Paolo Bossi
Session: Mini Oral session: Supportive and palliative care
Resources:
Webcast
General discussion and conclusions
Presenter: Melvin Lee Kiang Chua
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast
275MO - Phase III double blind placebo-controlled study of olanzapine for chemotherapy related anorexia in patients with advanced gastric, hepatopancreaticobiliary and lung cancer
Presenter: Prasanth Ganesan
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
276MO - Superior single agent effectiveness with plinabulin (Plin) versus (vs) placebo (Plac) for docetaxel (Doc)-induced neutropenia (DIN) prevention in non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Douglas Blayney
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast